A patent pool for combination method-of-use claims
Companies fear that testing a combination will hand a competitor a patent. A shared pool where combination patents are cross-licensed by default would remove the fear.
Method-of-use patents on combinations create a hold-up problem: whoever runs the trial may end up owing royalties to the other party or blocking them. Patent pools solved similar problems in DVD and telecoms standards. An oncology combination pool, entered voluntarily with fair, reasonable and non-discriminatory terms, would make combination discovery pre-competitive.
- Too many combinations to test · There are thousands of possible drug pairs and sequences. Trials can test a few dozen a year.
- Secrecy and intellectual property block collaboration · Companies with complementary drugs rarely test them together, and data that could answer questions stays locked up.
Pages like this
not linked directly; found by shared links- IdeaEvery approved cancer drug ships with a public combination-readiness data pack
Shares A standard cross-company combination agreement that takes weeks, not years, to sign, Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaA regulator-endorsed standard contract for inter-company combination trials
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaA legal right to obtain marketed cancer drugs at cost for combination trials
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaA publicly held library of investigational drugs available for academic combination trials
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaA permanent neutral non-profit sponsor for multi-company platform trials
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaAn oncology patent pool for combination trials across companies
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaA neutral platform trial for radiotherapy plus immunotherapy combinations
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.